188 related articles for article (PubMed ID: 8703689)
21. [Proposal for a diagnostic algorithm for the use of (18)F-FDG-PET in lung cancer].
Borrego-Dorado I; Vázquez-Albertino R
Rev Esp Med Nucl; 2009; 28(3):167-72. PubMed ID: 19558959
[No Abstract] [Full Text] [Related]
22. Risk stratification for lung nodules: Size isn't everything.
Eguchi T; Adusumilli PS
J Thorac Cardiovasc Surg; 2017 Jun; 153(6):1557-1562. PubMed ID: 28314535
[No Abstract] [Full Text] [Related]
23. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.
Gupta NC; Maloof J; Gunel E
J Nucl Med; 1996 Jun; 37(6):943-8. PubMed ID: 8683316
[TBL] [Abstract][Full Text] [Related]
24. Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer.
Lewis P; Griffin S; Marsden P; Gee T; Nunan T; Malsey M; Dussek J
Lancet; 1994 Nov; 344(8932):1265-6. PubMed ID: 7967988
[TBL] [Abstract][Full Text] [Related]
25. [F-18 fluorodeoxyglucose positron emission tomography in lung lesions].
Peschina W
Wien Med Wochenschr; 2002; 152(11-12):265-8. PubMed ID: 12138653
[TBL] [Abstract][Full Text] [Related]
26. Operative indications for lung cancer with satellite lesions.
Kushibe K; Kawaguchi T; Nishimoto Y; Takahama M; Tojo T; Taniguchi S
Asian Cardiovasc Thorac Ann; 2006 Aug; 14(4):316-20. PubMed ID: 16868106
[TBL] [Abstract][Full Text] [Related]
27. HCFA's coverage instructions for lung PET. Health Care Financing Administration.
Smith WJ
J Nucl Med; 1998 Jul; 39(7):28N-30N. PubMed ID: 9669378
[No Abstract] [Full Text] [Related]
28. Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET.
Hunter GJ; Choi NC; McLoud TC; Fischman AJ
J Nucl Med; 1993 Sep; 34(9):1571-3. PubMed ID: 8394885
[TBL] [Abstract][Full Text] [Related]
29. Mediastinal staging of non-small-cell lung cancer with positron emission tomography.
Chin R; Ward R; Keyes JW; Choplin RH; Reed JC; Wallenhaupt S; Hudspeth AS; Haponik EF
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2090-6. PubMed ID: 8520780
[TBL] [Abstract][Full Text] [Related]
30. 18F-deoxyglucose uptake in stage I non-small-cell lung cancer: time to move to randomized trials.
De Ruysscher D
J Thorac Oncol; 2014 Jan; 9(1):5-6. PubMed ID: 24346088
[No Abstract] [Full Text] [Related]
31. [Cost-effective PET investigations in oncology].
Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Galuska L; Trón L; Esik O
Magy Onkol; 2002; 46(3):203-23. PubMed ID: 12368917
[TBL] [Abstract][Full Text] [Related]
32. Observer variation of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in mediastinal staging of non-small cell lung cancer as a function of experience, and its potential clinical impact.
Smulders SA; Gundy CM; van Lingen A; Comans EF; Smeenk FW; Hoekstra OS;
Mol Imaging Biol; 2007; 9(5):318-22. PubMed ID: 17610119
[TBL] [Abstract][Full Text] [Related]
33. [Positron-emission tomography in the evaluation of lung cancer].
Torres García AJ; Carreras Delgado JL
Arch Bronconeumol; 1997 Dec; 33(11):553-5. PubMed ID: 9508470
[No Abstract] [Full Text] [Related]
34. Systematic review of the cost-effectiveness of positron-emission tomography in staging of non--small-cell lung cancer and management of solitary pulmonary nodules.
Cao JQ; Rodrigues GB; Louie AV; Zaric GS
Clin Lung Cancer; 2012 May; 13(3):161-70. PubMed ID: 22133290
[TBL] [Abstract][Full Text] [Related]
35. PET for the evaluation of solitary pulmonary nodules.
Fisher RE
J Nucl Med; 2009 Feb; 50(2):326; author reply 326-7. PubMed ID: 19164230
[No Abstract] [Full Text] [Related]
36. [Preoperative staging of non-small-cell bronchial carcinoma with PET].
Krieger G
Strahlenther Onkol; 2001 Mar; 177(3):161-2. PubMed ID: 11285775
[No Abstract] [Full Text] [Related]
37. [Positron emission-computed tomography in diagnosis and staging of lung neoplasms. Personal experience].
Mezzetti M; Calati AM; Schubert L
Minerva Chir; 2002 Aug; 57(4):461-5. PubMed ID: 12145576
[TBL] [Abstract][Full Text] [Related]
38. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795
[TBL] [Abstract][Full Text] [Related]
39. [18FDG in the primary staging of lung tumors. Results with a gamma camera and a 511 keV collimator].
Trampert L; Holle LH; Berberich R; Alexander C; Ukena D; Ruth T; Sybrecht GW; Oberhausen E
Nuklearmedizin; 1995 Jun; 34(3):79-86. PubMed ID: 7630746
[TBL] [Abstract][Full Text] [Related]
40. Positron emission tomography, bronchogenic carcinoma, and the adrenals.
Lamki LM
AJR Am J Roentgenol; 1997 May; 168(5):1361-2. PubMed ID: 9129445
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
